FDA Approves First COVID-19 Drug: The Antiviral Remdesivir
(AP) – The U.S. Food and Drug Administration has approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalization.
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.
— Gilead Sciences (@GileadSciences) October 22, 2020
It had been authorized for use on an emergency basis since spring, and now has become the first drug to win full U.S. approval for treating COVID-19.
Gilead says Veklury is approved for people at least 12 years old and weighing at least 88 pounds (40 kilograms) who need hospitalization for their coronavirus infection. It works by inhibiting a substance the virus uses to make copies of itself.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
- Police Release New Photos, Info In Mackenzie Lueck Murder Case (pageviews: 12951)
- Hale Center Theatre Orem Apologizes After Woman With Down Syndrome Asked To Leave Over Mask (pageviews: 6953)
- Dying Cancer Patient Forced From Utah County Home Even Though He Can Pay Rent (pageviews: 4684)
- Baby Born From 27-Year-Old Embryo Believed To Have Broken Record Set By Big Sister (pageviews: 4423)
- West Valley Family Angered After Christmas Decorations Were Stolen (pageviews: 3952)
- US Tightens Definition Of Service Animals Allowed On Planes (pageviews: 3064)
- Utah Reports 11 More People Have Died, 3,945 Tested Positive For COVID-19 (pageviews: 2903)
- Logan Woman Loses Two Family Members To COVID-19 (pageviews: 2467)
- Dying Cancer Patient Forced From Utah County Home Even Though He Can Pay Rent – KSLTV.com (pageviews: 2293)